Home › NDC Lookup › RxCUI directory › RxCUI 206206

Lansoprazole 30 MG Delayed Release Oral Capsule [Prevacid] — RxCUI 206206

RxNorm drug concept · Semantic branded drug
RxCUI 206206 Semantic branded drug · SBD ● Current RxNorm concept 3 FDA products 6 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI206206
Official nameLansoprazole 30 MG Delayed Release Oral Capsule [Prevacid]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asPrevacid 30 MG Delayed Release Oral Capsule
FDA products mapped3
Package NDCs mapped6
Reported Medicaid activity (SDUD)6,896 prescriptions · 24 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Lansoprazole: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It lowers stomach acid. Prescription forms treat ulcers, GERD, erosive esophagitis and conditions with too much acid. It is also used with antibiotics for H. pylori. Over-the-count...
  • Take it once a day, before eating, usually in the morning. Swallow capsules whole. Let orally disintegrating tablets dissolve on your tongue without chewing. For over-the-counter u...
  • For heartburn, the over-the-counter label says full effect can take 1 to 4 days, though some people feel relief within 24 hours. It is not meant for instant relief.
  • The most common are diarrhea, belly pain, nausea and constipation. Call your doctor if you get a severe rash, swelling, trouble breathing, diarrhea that will not clear, or muscle s...
📖 Read our full Lansoprazole guide →

🕸️ Concept Web — How Lansoprazole 30 MG Delayed Release Oral Capsule... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Lansoprazole 30 MG Delayed Release Oral Capsule [Prevacid] RxCUI 206206

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Lansoprazole 17128
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Prevacid 83156
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Lansoprazole Delayed Release Oral Capsule 378648
    • Lansoprazole Oral Product 1162545
    • Lansoprazole Pill 1162546
    • Lansoprazole Delayed Release Oral Capsule [Prevacid] 379705
    • Prevacid Oral Product 1177101
    • Prevacid Pill 1177102
    • Delayed Release Oral Capsule 316995
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

  5. Packs 2

    Fixed collections of drugs packaged and sold together, like dose packs.

Showing up to 8 concepts per family — 15 of 16 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Brand-Name Concepts

  • Lansoprazole 30 MG [Prevacid] SBDC · 541188
  • Lansoprazole Delayed Release Oral Capsule [Prevacid] SBDF · 379705
  • Prevacid Oral Product SBDG · 1177101
  • Prevacid Pill SBDG · 1177102
  • Prevacid BN · 83156
  • {4 (amoxicillin 500 MG Oral Capsule [Trimox]) / 2 (clarithromycin 500 MG Oral Tablet [Biaxin]) / 2 (lansoprazole 30 MG Delayed Release Oral Capsule [Prevacid]) } Pack [Prevpac] BPCK · 757969

📦 FDA Products & Package NDCs

3 products · 6 package NDCs
6 package NDCs map to RxCUI 206206 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
64764-0046-06 5 BLISTER PACK in 1 TRAY (64764-046-06) / 4 CAPSULE, DELAYE... Prevacid Takeda Pharmaceuticals America, Inc. 1995-05-10
64764-0046-13 100 CAPSULE, DELAYED RELEASE in 1 BOTTLE (64764-046-13) Prevacid Takeda Pharmaceuticals America, Inc. 1995-05-10
64764-0543-05 5 BLISTER PACK in 1 TRAY (64764-543-05) / 3 TABLET, ORALLY... Prevacid SoluTab Takeda Pharmaceuticals America, Inc. 2002-08-30
64764-0543-11 10 BLISTER PACK in 1 CARTON (64764-543-11) / 10 TABLET, ORA... Prevacid SoluTab Takeda Pharmaceuticals America, Inc. 2002-08-30
64764-0544-05 5 BLISTER PACK in 1 TRAY (64764-544-05) / 3 TABLET, ORALLY... Prevacid SoluTab Takeda Pharmaceuticals America, Inc. 2002-08-30
64764-0544-11 10 BLISTER PACK in 1 CARTON (64764-544-11) / 10 TABLET, ORA... Prevacid SoluTab Takeda Pharmaceuticals America, Inc. 2002-08-30
Observed labelers: Takeda Pharmaceuticals America, Inc. (6) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.